Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Actinium Pharmaceuticals, Inc. (ATNM) Presenting At 16th Annual BIO CEO & Investor Conference 0 comments
    Feb 5, 2014 2:39 PM | about stocks: ATNM

    Today before the opening bell, Actinium, a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, reported that it will be presenting at the 16th Annual BIO CEO & Investor Conference. The conference is taking place Monday, February 10 to Tuesday, February 11, 2014 at the Waldorf Astoria Hotel in New York City, New York. The company's President and CEO, Dr. Kaushik J. Dave will be presenting a company overview on Tuesday, February 11, 2014 at 1:30 pm EST.

    A telecast of the presentation will be given. Investors and those seeking to watch the presentation are advised to visit the following link for the presentation at 1:30 pm EST on February 11, 2014: www.veracast.com/webcasts/bio/ceoinvesto....

    Joining a few minutes ahead of time is advisable, for best viewing results.

    Actinium Pharmaceuticals is a New York-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The Company's lead radiopharmaceutical Iomab(NYSE:TM)-B will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant.

    For more information, visit: actiniumpharmaceuticals.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: ATNM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.